You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR AMIDATE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for AMIDATE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01823328 ↗ Ketamine Versus Etomidate for Rapid Sequence Intubation Completed Hennepin Healthcare Research Institute Phase 4 2013-09-01 The purpose of this study is to compare the effectiveness and safety of ketamine and etomidate during rapid sequence intubation (RSI).
NCT01823328 ↗ Ketamine Versus Etomidate for Rapid Sequence Intubation Completed Minneapolis Medical Research Foundation Phase 4 2013-09-01 The purpose of this study is to compare the effectiveness and safety of ketamine and etomidate during rapid sequence intubation (RSI).
NCT02453373 ↗ Helping Stroke Patients With ThermoSuit Cooling Recruiting Geisinger Clinic N/A 2017-01-25 The aim of this study is to assess the feasibility of using the Life Recovery Systems ThermoSuit Device to induce therapeutic hypothermia (32-34°C) in victims of ischemic stroke. This feasibility clinical study will enroll a total of 30 patients with acute ischemic stroke at four clinical centers. Subjects will receive hypothermia plus conventional therapy (such as IV-tPA and/or neurothrombectomy therapies if indicated). Endpoints will include feasibility of cooling, adverse events, and neurological recovery in comparison with matched historical controls.
NCT02453373 ↗ Helping Stroke Patients With ThermoSuit Cooling Recruiting Tulane University School of Medicine N/A 2017-01-25 The aim of this study is to assess the feasibility of using the Life Recovery Systems ThermoSuit Device to induce therapeutic hypothermia (32-34°C) in victims of ischemic stroke. This feasibility clinical study will enroll a total of 30 patients with acute ischemic stroke at four clinical centers. Subjects will receive hypothermia plus conventional therapy (such as IV-tPA and/or neurothrombectomy therapies if indicated). Endpoints will include feasibility of cooling, adverse events, and neurological recovery in comparison with matched historical controls.
NCT02453373 ↗ Helping Stroke Patients With ThermoSuit Cooling Recruiting Life Recovery Systems N/A 2017-01-25 The aim of this study is to assess the feasibility of using the Life Recovery Systems ThermoSuit Device to induce therapeutic hypothermia (32-34°C) in victims of ischemic stroke. This feasibility clinical study will enroll a total of 30 patients with acute ischemic stroke at four clinical centers. Subjects will receive hypothermia plus conventional therapy (such as IV-tPA and/or neurothrombectomy therapies if indicated). Endpoints will include feasibility of cooling, adverse events, and neurological recovery in comparison with matched historical controls.
NCT02924090 ↗ Hyperventilation Combined With Etomidate or Ketamine Anesthesia in ECT Treatment of Major Depression Unknown status University of Manitoba Phase 4 2016-09-01 This is a randomized controlled study assessing the effect of pre-emptive hyperventilation on ECT seizure duration, cerebral desaturation and remission of depressive symptoms in patients with Major Depressive Disorder. Comparison of etomidate and ketamine on remission of depressive symptoms with and without pre-emptive hyperventilation will also be studied.
NCT03545503 ↗ Evaluating the Hemodynamic Effects of Ketamine Versus Etomidate During Rapid Sequence Intubation Recruiting New Hanover Regional Medical Center Phase 4 2018-01-01 The purpose of this study is to compare the hemodynamic effects of ketamine v etomidate during rapid sequence intubation (RSI) in the pre-hospital and emergency department setting.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for AMIDATE

Condition Name

Condition Name for AMIDATE
Intervention Trials
Anesthesia 1
Brain Ischemia 1
Complication 1
Depression 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for AMIDATE
Intervention Trials
Brain Ischemia 1
Hyperventilation 1
Depressive Disorder, Major 1
Depressive Disorder 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for AMIDATE

Trials by Country

Trials by Country for AMIDATE
Location Trials
United States 6
Canada 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for AMIDATE
Location Trials
Louisiana 1
Minnesota 1
California 1
North Carolina 1
South Carolina 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for AMIDATE

Clinical Trial Phase

Clinical Trial Phase for AMIDATE
Clinical Trial Phase Trials
Phase 4 4
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for AMIDATE
Clinical Trial Phase Trials
Recruiting 2
Completed 2
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for AMIDATE

Sponsor Name

Sponsor Name for AMIDATE
Sponsor Trials
Hennepin Healthcare Research Institute 1
Minneapolis Medical Research Foundation 1
Geisinger Clinic 1
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for AMIDATE
Sponsor Trials
Other 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.